Horizon Europe is the European Union (EU) funding programme for the period 2021 – 2027, which targets the sectors of research and innovation. The programme’s budget is around € 95.5 billion, of which € 5.4 billion is from NextGenerationEU to stimulate recovery and strengthen the EU’s resilience in the future, and € 4.5 billion is additional aid.
The action will start with an assessment of the large number of funded actions in the field of biotechnology and bioengineering (EU – including European partnerships (in particular under the Joint UndertakingBio-based Europe Joint Undertaking (CBE JU)), EU missions and European research infrastructure programmes in biotechnology, such as EU-IBISBA, as well as others at national, regional and international level), related to industrial, environmental, marine and agri-food biotechnology (Note: according to the current definition of the EU Bioeconomy Strategy, biotechnology in the health sector is not in scope), as well as parallel broader scientific developments on the same topics.
The action will then provide scientifically robust assessment of the social, economic and environmental benefits and risks of biotechnologies and biomanufacturing and deliver recommendations in form of a consolidated EU vision and research and innovation agenda, on future trends and main innovation avenues. This action will contribute to the implementation of the EU biotechnology and biomanufacturing Initiative, in particular by developing guidance to stakeholders, such as SMEs, start-ups or civil society.
It should also explore the role of biotechnology and biomanufacturing in terms of knowledge needs around the potential positive impacts and potential risks of biotechnology, including on biodiversity and ecosystems, e.g., resource efficiency, sustainable biomass management, impacts on air, water and soil quality or capacity of bio-based systems to enable a sustainable carbon management and better understanding of the carbon removal potential of bio-based economies.
Furthermore, the action should inform the policy makers on national level, as an input to new or updated national bioeconomy strategies or roadmaps. Given that biotechnology has been identified as a critical technology from the economic security perspective[2] , due to its cross-cutting nature, and also as one of the technologies prioritised in the Strategic Technologies for Europe Platform (STEP) Regulation[3], such aspects should be covered by the present action.
100%
Expected EU contribution per project: €2.00 million.
A number of non-EU/non-Associated Countries that are not automatically eligible for funding have made specific provisions for making funding available for their participants in Horizon Europe projects.
Research and Innovation Foundation
29a Andrea Michalakopoulou, 1075 Nicosia,
P.B. 23422, 1683 Nicosia
Telephone: +357 22205000
Fax: +357 22205001
Email: support@research.org.cy
Website: https://www.research.org.cy/en/
Contact Persons:
Marcia Trillidou
Scientific Officer A’
Email: trillidou@research.org.cy
Dr. Mary Economou
Scientific Officer
Email: meconomou@research.org.cy